Risk Assessment and Categorization Tool (@RACT)

Risk Assessment and Categorization Tool (@RACT)2018-10-01T15:47:16+00:00

Kickstart your Risk-based Monitoring activities with @RACT®

@RACT – “attract” – is a web-based professional risk assessment tool designed specifically for CRO, Pharma, Biotech and Medtech enterprises transiting to risk-controlled strategies and processes to meet ICH E6 (R2) compliance.

Do you want to learn more about proper clinical risk management before you decide?

How to choose what you really need? Simply, see it!

Join the live demo
ICON Start with RBM Basics

Start with the RBM Basics

@RACT offers all essential features for a smooth introduction to RBM:

  • Risk Identification
  • Risk Assessment
  • Risk Mitigation

You can select from an array of validated, customizable TransCelerate and Cyntegrity therapy specific RACT catalogs, and collaborate with as many users as you need.

ICON get smarter

Get Smarter with Every Study

The intuitive design will help you save time and effort when setting up the next study. @RACT software contains:

  • Built-in intelligence
  • Self-learning features
  • And is easy to operate
ICON ready to go with RBM Basics

@RACT is Ready
to Go

@RACT is delivered to you as a SaaS (software as a service) cloud application:

  • Direct access upon subscription
  • Login details via email
  • User friendly welcome wizard for quick tour

Tailor @RACT to Your Needs

@RACT is a collection of features bundled in four upgradeable versions:

 

Available Seat Bundles
GCP Validated
TransCelerate RACTs
Audit Trail
Export to Excel
Adaptable Questionnaires
Multi-User Collaboration
Knowledge-Library of Risks
Library of Mitigation Actions
KRI Library Access
RBM Plan Template
Therapy Specific RACTs

@RACT

good for single user

free version
Available Seat Bundles: 1
GCP Validated
TransCelerate RACTs
Audit Trail
Export to Excel
Adaptable Questionnaires
Multi-User Collaboration
Knowledge-Library of Risks
Library of Mitigation Actions
KRI Library Access
RBM Plan Template
Therapy Specific RACTs

@RACT Professional

ideal for small companies

from €299,00 / month
Available Seat Bundles : 5 / 15 / 45
GCP Validated
TransCelerate RACTs
Audit Trail
Export to Excel
Adaptable Questionnaires
Multi-User Collaboration
Knowledge-Library of Risks
Library of Mitigation Actions
KRI Library Access
RBM Plan Template
Therapy Specific RACTs

@RACT Pro+

great for larger teams

from €598,00 / month
Available Seat Bundles : 5 / 15 / 45
GCP Validated
TransCelerate RACTs
Audit Trail
Export to Excel
Adaptable Questionnaires
Multi-User Collaboration
Knowledge-Library of Risks
Library of Mitigation Actions
KRI Library Access
RBM Plan Template
Therapy Specific RACTs

Enterprise

no limitations

on request
Available Seat Bundles : unlimited seats
GCP Validated
TransCelerate RACTs
Audit Trail
Export to Excel
Adaptable Questionnaires
Multi-User Collaboration
Knowledge-Library of Risks
Library of Mitigation Actions
KRI Library Access
RBM Plan Template
Therapy Specific RACTs

Designed for Clinical Purpose

We designed @RACT with clinical study teams in mind, and the regulatory challenges ahead that require a safe and evidence-based study environment. All the features that Excel doesn’t offer, such as central, secure and scalable data storage, audit trails, multi-user collaboration, artificial intelligence, and experienced user support, prepare the study team for predictable success.

We are There to Help You

No need to mention that we are on standby to help you with any question you may have. If you require more in-depth consultation we can partner with you to provide ongoing support as your extended clinical research department.

CONTACT US

Still Thinking About It?

Why not subscribe to our FREE 30-day trial and save 17% off your 1st-year @RACT-Pro subscription as our preferred “RBM Champion” subscriber?

YES, I SUBSCRIBE

@RACT-Pro, the Professional Way of Dealing with Risks in Clinical Trials



Upcoming Events

  1. DIA Europe 2019

    February 5, 2019 - February 7, 2019

Register Today!

Get Free Test Access